reports
MSCI Inc: 1 director
A director at MSCI Inc sold 9,000 shares at 471.689USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Vornado Declares Quarterly Dividends On Preferred Shares
Vornado Declares Quarterly Dividends On Preferred Shares NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that its Board of Trustees has declared the following quarterly preferred dividends: Series A Convertible$.8125000per shareSeries L Cumulative Redeemable$.3375000per shareSeries M Cumulative Redeemable$.3281250per shareSeries N Cumulative Redeemable$.3281250per shareSeries O Cumulative Redeemable$.2781250per share In each case, dividends are payable on July 1, 2024 to shareholders of record on June 17, 2024. Vornado Realty Trust is a full...
Pfizer Reports First-Quarter 2024 Results
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6). The first-quarter 2024 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizer’s R&D pipeline can be found at . EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: “We delivered strong performance in our non-COVID product portfolio in the first quarter of 2024, including...
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic ...
NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE)-- (NYSE: PFE) and (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. "Recurrent or metastatic cervical cancer is a particularly devastating and mostly incurable disease, and patients are in need of survival-extending treatment options,” said Chris Boshoff, M.D., Ph.D., Chief...
NXP Semiconductors Reports First Quarter 2024 Results
NXP Semiconductors Reports First Quarter 2024 Results EINDHOVEN, The Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the first quarter, which ended March 31, 2024. “NXP delivered quarterly revenue of $3.13 billion, in-line with the midpoint of guidance with all our focus end-markets performing as expected. Our first-quarter results, guidance for the second quarter, and our early views into the second half of the year underpin a cautious optimism that NXP is successfully navigating through this industry-wide cyclic...
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicin...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) highlights its progress in advancing new potential standards of care in Oncology at the 2024 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May 31 to June 4 in Chicago. More than 50 abstracts, including 11 oral presentations, will be presented from Pfizer’s broadened portfolio of approved and pipeline therapies across the company’s key tumor areas and core scientific modalities, including small molecules, antibody-drug conjugates (ADCs) and bispecific antibodies. “We are excited to participate in our first ASCO A...
- Jonathan Moreland
MSCI MSCI INC. CLASS A
LGND LIGAND PHARMACEUTICALS INCORPORATED
CTRN CITI TRENDS INC.
BANC BANC OF CALIFORNIA INCORPORATED
LIND LINDBLAD EXPEDITIONS HOLDINGS
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
BRT BRT APARTMENTS
LOVE LOVESAC
FVCB FVCBANKCORP
HROW HARROW HEALTH INC.
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
HQL CAPRICOR THERAPEUTICS
AUID TEKLA LIFE SCIENCES INVESTORS
BHVN IPSIDY INC.
MAIA BIOHAVEN LTD
MEGI MAIA BIOTECHNOLOGY INC
NPCT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
RXO_w NUVEEN CORE PLUS IMPACT FD
ZURA RXO INC
ABEO ZURA BIO LTD
STCN ABEONA THERAPEUTICS INC.
KRRO STEEL CONNECT INC
EP KORRO BIO INC
ASGI EMPIRE PETROLEUM CORP
INTZ ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYPT INTRUSION INC
IZEA EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
- Jonathan Moreland
LGND LIGAND PHARMACEUTICALS INCORPORATED
BANC BANC OF CALIFORNIA INCORPORATED
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
HQL TEKLA LIFE SCIENCES INVESTORS
MAIA MAIA BIOTECHNOLOGY INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
NPCT NUVEEN CORE PLUS IMPACT FD
RXO_w RXO INC
ABEO ABEONA THERAPEUTICS INC.
LSXMA LIBERTY SIRIUSXM GROUP
LSXMK ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
ASGI IZEA WORLDWIDE INC
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a ...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing antibodies to adeno-associated virus serotype Rh74var (AAVRh74var) capsid as detected by an FDA-approved test. BEQVEZ is a one-time treatment that is designed to ena...
Vornado Announces First Quarter Earnings Release Date and Conference C...
Vornado Announces First Quarter Earnings Release Date and Conference Call Information NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that it will file its quarterly report on Form 10-Q for the quarter ended March 31, 2024 with the U.S. Securities and Exchange Commission and issue its first quarter earnings release on Monday, May 6, 2024, after the New York Stock Exchange has closed. The Company will host a quarterly earnings conference call and an audio webcast on Tuesday, May 7, 2024 at 10:00 a.m. Eastern Time (ET). The conference call can b...
Pfizer Declares Second-Quarter 2024 Dividend
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company’s common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The second-quarter 2024 cash dividend will be the 342nd consecutive quarterly dividend paid by Pfizer. About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the stan...
Coherent Announces Support of DEI-Related Educational Initiatives Thro...
Coherent Announces Support of DEI-Related Educational Initiatives Through HBCU/MIS and the Optica Foundation PITTSBURGH, April 23, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a leader in materials, networking, and lasers, today announced a $500,000 sponsorship of two educational initiatives targeted to increase diversity, equity, and inclusion (DEI) in entrepreneurship, innovation, and advanced technology: the HBCU/MI Entrepreneurship & Innovation initiative by Leadership Needed Foundation and the for Black scientists. The HBCU/MI Entrepreneurship and Innovation initiative b...
Earth Day 2024: Coherent Corp. Announces Milestones in its Sustainabil...
Earth Day 2024: Coherent Corp. Announces Milestones in its Sustainability Journey Company Sets a 2040 Net-Zero Goal, Increases Its Renewable Electricity Use to 70%, and Joins the Responsible Business Alliance PITTSBURGH, April 23, 2024 (GLOBE NEWSWIRE) -- In support of Earth Day 2024, Coherent Corp. (NYSE: COHR), a global leader in materials, networking, and lasers, announced today that the company is now obtaining approximately 70% of its global electricity needs from renewable energy sources. In total, this represents over 500 million kWh of renewable electricity per year, thereby avo...
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Mult...
NEW YORK--(BUSINESS WIRE)-- . (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO® (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options. “For healthcare teams treating patients with ...
Coherent Announces Date of FY2024 Third-Quarter Conference Call
Coherent Announces Date of FY2024 Third-Quarter Conference Call PITTSBURGH, April 18, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in materials, networking, and lasers, announced today that the company will release its financial results for the quarter ended March 31, 2024, in a shareholder letter posted on Coherent’s website at after market close on Monday, May 6. Coherent’s management will host a conference call to discuss these results on Tuesday, May 7, at 8:00 a.m. ET. Individuals wishing to listen to the live webcast of the call can access the event at the...
SL Green and Vornado Announce 280 Park Avenue Mezzanine Loan Repayment
SL Green and Vornado Announce 280 Park Avenue Mezzanine Loan Repayment NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG) and Vornado Realty Trust (NYSE: VNO) modified and extended the $125.0 million mezzanine loan on 280 Park Avenue and subsequently repaid the loan for $62.5 million. Newmark advised the parties on the transaction. About SL Green Realty Corp. SL Green Realty Corp., Manhattan's largest office landlord, is a fully integrated real estate investment trust, or REIT, that is focused primarily on acquiring, managing and maximizing the value of Manh...
SL Green and Vornado Announce 280 Park Avenue Mortgage Loan Refinancin...
SL Green and Vornado Announce 280 Park Avenue Mortgage Loan Refinancing NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG) and Vornado Realty Trust (NYSE: VNO) closed on a modification and extension of the $1.075 billion securitized mortgage on 280 Park Avenue. The modification extended the maturity date to September 2026, with the partnership’s option to extend to a fully extended maturity date of September 2028. The interest rate was maintained through the fully extended maturity date at 1.78% over Term SOFR. About SL Green Realty Corp. SL Green Realty Corp...
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting...
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual-only 2024 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 25, 2024. Pfizer has designed the virtual Annual Meeting to ensure that its shareholders who attend the virtual-only Annual Meeting will be afforded comparable rights and opportunities to participate as they would at an in-person meeting. Beginning today, shareholders can find additional information on accessing and registering for the virtual meeting at . On the day of t...
NXP Semiconductors Announces Conference Call to Review First Quarter 2...
NXP Semiconductors Announces Conference Call to Review First Quarter 2024 Financial Results EINDHOVEN, The Netherlands, April 11, 2024 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it will release financial results for the first quarter 2024 after the close of normal trading on the NASDAQ Global Select Market on Monday, April 29, 2024. The company will host a conference call with the financial community on Tuesday, April 30, 2024 at 8:00 a.m. U.S. Eastern Daylight Time (EDT). Earnings Conference Call Details Interested parties may pre-register for the or ob...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.